MedTrace Logo

Sodium Management in Acute Neurological Injury

NCT01558843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-05-01

No results posted yet for this study

Summary

This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).

Conditions

  • This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Gretchen Brophy, Pharm.D · VCU

  • Theresa Murphy-Human, Pharm.D. · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-01
Primary Completion
2014-10-01
Completion
2016-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01558843 on ClinicalTrials.gov